Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.5K
Overview
51.5K
What is the Immune System?01:38

What is the Immune System?

127.6K
Overview
127.6K
Cancer Vaccines01:30

Cancer Vaccines

1.0K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K
Protection of Alcohols02:31

Protection of Alcohols

8.1K
This lesson delves into the concept of protection and deprotection of a functional group fundamental to synthetic organic chemistry. These phenomena are explained in the context of aliphatic and aromatic alcohols.
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
8.1K
Zones of Protection01:16

Zones of Protection

793
In power systems, the entire setup is divided into protective zones to isolate faults and protect the rest of the network. These zones include generators, transformers, buses, transmission lines, distribution lines, and motors. Each zone can be visualized as a separate room in a house, with each room protected by its own circuit breaker.
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
793
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

923
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
923

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted delivery of the BCG vaccine to dendritic cells improves protective efficacy against Mycobacterium tuberculosis.

Vaccine·2026
Same author

ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosis.

Nature communications·2026
Same author

Efficacy of Inhalable Endolysin Cpl-1 Formulations in Combination with Gentamicin or Endolysin Pal in a Murine Lung Infection Model.

Pharmaceutical research·2026
Same author

ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent Antimycobacterials.

ACS infectious diseases·2025
Same author

Tissue-wide profiling of human lungs reveals spatial sequestration of macrophages in tuberculosis.

bioRxiv : the preprint server for biology·2025
Same author

Upper respiratory tract immunization with Pam<sub>2</sub>Cys-adjuvanted spike protein vaccine achieves sterilizing protection against SARS-CoV-2.

Frontiers in immunology·2025
Same journal

Projected health and economic impact of PCV20 vaccination in UK children: a dynamic transmission model.

Expert review of vaccines·2026
Same journal

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Whole cell and acellular pertussis vaccines - rethinking the evidence.

Expert review of vaccines·2026
Same journal

Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic.

Expert review of vaccines·2026
Same journal

Narrative shielding and prebunking: a synergistic strategy against vaccine hesitancy in pediatrics.

Expert review of vaccines·2026
See all related articles

Related Experiment Video

Updated: Jan 28, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.0K

Deciphering protective immunity against tuberculosis: implications for vaccine development.

Claudio Counoupas1,2, James A Triccas1, Warwick J Britton1,2

  • 1a Tuberculosis Research Program Centenary Institute , The University of Sydney , Camperdown , NSW , Australia.

Expert Review of Vaccines
|February 23, 2019
PubMed
Summary
This summary is machine-generated.

Developing effective tuberculosis (TB) vaccines is crucial. While CD4+ T cells are vital, new research explores other immune responses like B cells and antibodies as potential correlates of protection for TB vaccines.

Keywords:
T lymphocytesTuberculosisclinical trialscorrelates of protectionvaccine

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.0K
Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.6K

Related Experiment Videos

Last Updated: Jan 28, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.0K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.0K
Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.6K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Effective tuberculosis (TB) vaccines are critical for global TB control.
  • A major challenge is the absence of reliable correlates of protection, hindering vaccine development.
  • Animal model efficacy does not consistently predict human outcomes.

Purpose of the Study:

  • To review immune mechanisms contributing to protective immunity against TB post-vaccination.
  • To correlate these mechanisms with efficacy data from animal models and human clinical trials.
  • To identify potential correlates of protection for future TB vaccine development.

Main Methods:

  • Literature review of current knowledge on immune responses to TB vaccination.
  • Analysis of data from animal protection studies and human clinical trials.
  • Focus on immune mechanisms beyond conventional T cell responses.

Main Results:

  • Recent clinical trials show promising efficacy for three distinct TB vaccine approaches.
  • Conventional CD4+ and CD8+ T cell responses have not shown clear correlations with vaccine efficacy.
  • Emerging research highlights the potential role of donor unrestricted T cells, B lymphocytes, and antibodies.

Conclusions:

  • Identifying correlates of protection is essential for advancing TB vaccine development.
  • Further investigation into alternative immune responses is warranted.
  • Prospective studies on vaccinated individuals in successful trials will be key to validating new correlates of protection.